Tag: palbociclib

September 20, 2021 Off

Novartis, Harmonia move to Phase III trial to test Kisqali vs. Ibrance in patients with advanced breast cancer

Novartis said Monday it has started a collaboration with SOLTI Innovative Cancer Research (SOLTI) on HARMONIA, an international, randomized, Phase III, multicenter, open-label study of Kisqali (ribociclib) versus Ibrance (palbociclib),.

April 4, 2019 Off

U.S. FDA Approves IBRANCE for the Treatment of Men with HR+, HER2- Metastatic Breast Cancer

By BusinessWire

Approval of expanded indication based predominately on real-world data NEW YORK–(BUSINESS WIRE)–Pfizer (NYSE:PFE) today announced that the U.S. Food and…